Latest Institutional news, Institutional news
In Rare Move, FDA Panel Gives Support to Controversial ALS Drug in Second Review
posted September 8th
Therapies Compared for Newly Diagnosed Multiple Sclerosis 
Initial Rx Length Tied to Long-Term Use of Z-Drugs 
Azacitidine + Venetoclax Tied to Improved Event-Free Survival in Adults With AML 
Updated Recommendations Address Medications to Prevent Migraine in Adults Related Articles
AAP Issues Recommendations for Pediatric RSV Vaccination in 2026-2027 Season 
Trends Reported in Vaccination Coverage for Adolescents for 2025 .jpeg)
Higher Intake of Saturated, Animal Fats May Increase Mortality in Prostate Cancer 
Use of GLP-1 Receptor Agonists Increasing Among Children With Obesity Monthly Specialist Briefings
Stay Connected
